The AI Transformation of 2026: Enveda’s $311M Biotech Milestone and the Shifting Paradigms in Tech and Cybersecurity
AI biotech startup Enveda has secured a massive $311 million Series E funding round to scale nature-derived drug discovery, highlighting a broader industry trend of AI reshaping biotech, cybersecurity, and consumer media.
AI资讯BiotechEnveda
109 views
